Cover Story
Clinical
Imatinib—the pathbreaking cancer drug that gave Philadelphia chromosome-positive chronic myeloid leukemia patients near-normal life expectancies—now stands poised to save even more lives.
In Brief
Clinical Roundup
Drugs & Targets
NCI Trials
NCI Trials for November 2023
The National Cancer Institute approved the following clinical research studies last month.
Trending Stories
- When tobacco companies sponsored the Olympics
- U.S. News rankings for cancer hospitals shift again with inclusion of Medicare Advantage data
Rankings now include a list of Best Regional Hospitals for Equitable Access - Kamala Harris widely expected to continue Cancer Moonshot; Conservatives present their vision in Project 2025
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- ODAC vote will likely lead to three-arm and four-arm designs–and pragmatic trials–for perioperative indications
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch